4.4 Article

Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women

Journal

NEUROENDOCRINOLOGY
Volume 106, Issue 2, Pages 148-157

Publisher

KARGER
DOI: 10.1159/000473893

Keywords

Neurokinin B; Kisspeptin; Gonadotropin-releasing hormone; Menopause; Luteinising hormone pulsatility; Hot flashes

Funding

  1. Wellcome Trust Scottish Translational Medicine and Therapeutics Initiative (STMTI) [102419/Z/13/A]
  2. MRC [G0701682]
  3. AstraZeneca [AZD4901/MLE4901]

Ask authors/readers for more resources

Objectives: Neurokinin B (NKB) and kisspeptin are obligate for normal gonadotropin secretion, and links between gonadotropin-releasing hormone (GnRH) pulsatility and vasomotor symptoms have been proposed. Using a selective NKB receptor (NK3R) antagonist, the role of NKB in the hypergonadotropic state in menopausal women was explored. Methods: Eleven postmenopausal women were administered the NK3R antagonist MLE4901 at 40 mg twice daily orally for 7 days. Ten-minute blood sampling for 8 h was performed before and on the last day of NK3R antagonist treatment for luteinising hormone (LH) pulsatility analysis with kisspeptin-10 (0.3 mu g/kg i.v. bolus) administered at 6 h on both days. Hot flash frequency and severity were self-reported for 7 days before and during NK3R antagonist administration. Results: LH fell from 29.3 +/- 4.1 to 24.4 +/- 3.8 IU/L (p < 0.05) after 7 days of NK3R antagonist treatment, with no change in follicle-stimulating hormone (FSH). Basal (nonpulsatile) LH secretion was reduced (549.0 +/- 70.8 vs. 366.1 +/- 92.1 IU/L/6 h, p = 0.006), and while the LH pulse frequency did not change in the group as a whole (from 0.8 +/- 0.1 to 0.7 +/- 0.1 pulses/h, ns), it did fall in the 8 women with hot flashes (from 1.0 +/- 0.1 to 0.7 +/- 0.1 pulses/h, p < 0.05). These women also reported a reduction in hot flash frequency (from 3.4 +/- 1.2 to 1.0 +/- 0.6 hot flashes/day, p = 0.008) whilst taking the NK3R antagonist. Kisspeptin-10 did not affect LH secretion with or without the NK3R antagonist. Conclusions: The administration of an NK3R antagonist indicates a role for NKB in the regulation of LH/GnRH in postmenopausal women, whereas the lack of response to kisspeptin may reflect the hypo-oestrogenic state. These data support a link of LH/GnRH pulsatility and vasomotor symptoms with NK3R antagonism as a potential therapeutic approach. (C) 2017 The Author(s) Published by S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available